{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:10:22Z","timestamp":1790511022737,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":433,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.bbmt.2013.11.013","type":"journal-article","created":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T11:30:48Z","timestamp":1385119848000},"page":"285-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Live Attenuated Varicella-Zoster Vaccine in Hematopoietic Stem Cell Transplantation Recipients"],"prefix":"10.1016","volume":"20","author":[{"given":"Nicolas C.","family":"Issa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco M.","family":"Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houry","family":"Leblebjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9310-8752","authenticated-orcid":false,"given":"Alicia","family":"Galar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Soiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey R.","family":"Baden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.11.013_bib1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21152","article-title":"Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"83","author":"Asano-Mori","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2013.11.013_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.bmt.1705191","article-title":"Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience","volume":"37","author":"Berman","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.013_bib3","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation\u2014a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.013_bib4","first-page":"277","article-title":"Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications","volume":"13","author":"Han","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.013_bib5","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/infdis\/152.6.1172","article-title":"Infection with varicella-zoster virus after marrow transplantation","volume":"152","author":"Locksley","year":"1985","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2013.11.013_bib6","first-page":"495","article-title":"Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia","volume":"10","author":"Sempere","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.013_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1702190","article-title":"Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir","volume":"25","author":"Steer","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.013_bib8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbmt.2010.10.025","article-title":"High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation","volume":"17","author":"Su","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.013_bib9","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.013_bib10","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A\u00a0vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2013.11.013_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bmt.1704959","article-title":"The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation","volume":"35","author":"Thomson","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.013_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ajh.22196","article-title":"Experience with use of Zostavax((R)) in patients with hematologic malignancy and hematopoietic cell transplant recipients","volume":"87","author":"Naidus","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2013.11.013_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.013_bib14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.013_bib15","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.bbmt.2013.11.013_bib16","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2013.11.013_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archpedi.1984.02140430012004","article-title":"Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies","volume":"138","author":"Arbeter","year":"1984","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.bbmt.2013.11.013_bib18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/infdis\/161.4.661","article-title":"Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group","volume":"161","author":"Gershon","year":"1990","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2013.11.013_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/infdis\/158.1.132","article-title":"Immunization of healthy adults with live attenuated varicella vaccine","volume":"158","author":"Gershon","year":"1988","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2013.11.013_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1542\/peds.81.4.512","article-title":"Live attenuated varicella vaccine in healthy 12- to 24-month-old children","volume":"81","author":"Johnson","year":"1988","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbmt.2013.11.013_bib21","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.1985.03360170075034","article-title":"Live Oka\/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment","volume":"254","author":"Weibel","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2013.11.013_bib22","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM198405313102201","article-title":"Live attenuated varicella virus vaccine. Efficacy trial in healthy children","volume":"310","author":"Weibel","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2013.11.013_bib23","first-page":"604","article-title":"Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989","volume":"87","author":"White","year":"1991","journal-title":"Pediatrics"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113005326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113005326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:47:48Z","timestamp":1761058068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113005326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1083879113005326"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.11.013","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live Attenuated Varicella-Zoster Vaccine in Hematopoietic Stem Cell Transplantation Recipients","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}